VIPoma laboratory findings

VIPoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating VIPoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
VIPoma laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of VIPoma laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on VIPoma laboratory findings
CDC on VIPoma laboratory findings
VIPoma laboratory findings in the news
Blogs on VIPoma laboratory findings
Directions to Hospitals Treating VIPoma
Risk calculators and risk factors for VIPoma laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Laboratory Findings

Serum vasoactive intestinal polypeptide (VIP) Pancreatic polypeptide levels and neurotensin levels Low serum potassium and bicarbonate levels secondary to faecal loss.Hypomagnesaemia, hypercalcaemia Low basal gastric acid output.

References

Template:WikiDoc Sources